ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patientsTeilah Kathryn Huth, Sonya Marshall‐Gradisnik|Journal of Translational Medicine|2016Cited by 47